Molecular and antigenic structure of nicotinic acetylcholine receptors

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 71-86

  Lindstrom, Jon ^a   Peng, Xiao ^a   Kuryatov, Alexander ^a   Lee, Edward ^a   Anand, René ^a   Gerzanich, Volodymyr ^a   Wang, Fan ^a   Wells, Gregg ^a   Nelson, Mark ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINESTERASE INHIBITOR; COMPLEMENTARY DNA; GLUTAMATE RECEPTOR; IMMUNOSUPPRESSIVE AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

AMINO TERMINAL SEQUENCE; ANTIGEN SPECIFICITY; AUTOIMMUNITY; B LYMPHOCYTE; CILIARY GANGLION; CONFERENCE PAPER; DNA SEQUENCE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN DOMAIN; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; T LYMPHOCYTE;

EID: 0031879610     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10910.x     Document Type: Conference Paper

References (72)

1. LINDSTROM, J. 1996. Neuronal nicotinic acetylcholine receptors. In Ion Channels. Volume 4, p. 377-450. Plenum. New York.
2. MCGEHEE, D. & L. ROLE. 1995. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57: 521-546.
3. BARNARD, E. 1992. Receptor classes and the transmitter-gated ion channels. Trends Biochem. Sci. 17: 368-374.
4. CONROY, W., A. VERNALLIS & D. BERG. 1992. The α5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron 9: 1-20.
5. WANG, F., V GERZANICH, G. WELLS, R. ANAND, X. PENG, K. KEYSER & J. LINDSTROM. 1996. Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2, and β4 subunits. J. Biol. Chem. 271: 17656-17665.
6. UNWIN, N. 1995. Acetylcholine receptor channel imaged in the open state. Nature 373: 37-43.
7. KARLIN, A. & M. AKABAS. 1995. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15: 1231-1244.
8. TZARTOS, S., M. SEYBOLD & J. LINDSTROM. 1982. Specificity of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 79: 188-192.
9. TZARTOS, S., M. CUNG, P. DEMANGE, H. LOUTRARI, A. MAMALAKI, M. MARRAUD, I. PAPADOULI, C. SAKARELLOS & V TSIKARIS. 1991. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies. Mol. Neurobiol. 5: 1-29.
10. LINDSTROM, J., D. SHELTON & Y. FUJI. 1988. Myasthenia gravis. Adv. Immunol. 42: 233-284.
11. DRACHMAN, D. 1994. Myasthenia gravis. N. Eng. J. Med. 330: 1797-1810.
12. WANG, Z., J. QIAO & H. LINK. 1993. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Neuroimmunol. 44: 209-214.
13. WANG, Z., J. QIAO, A. MELMS & H. LINK. 1993. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 152: 394-404.
14. WANG, Z., H. LINK, A. LJUNGDAHL, B. HOJEBERG, J. LINK, B. HE, J. QIAO, A. MELMS & T. OLSSON. 1994. Induction of interferon-γ, interleukin-4, and transforming growth factor-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157: 353-368.
15. WANG, Z., J. HUANG, T. OLSSON, B. HE & H. LINK. 1995. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J. Neurol. Sci. 128: 167-175.
16. MA, C., G. ZHANG, B. XIAO, J. LINK, T. OLSSON & H. LINK. 1995. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 58: 51-60.
17. MA, C., G. ZHANO, B. XIAO, Z. WANG, J. LINK, T. OLSSON & H. LINK. 1996. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-γ-expressing Th1-like cells and up-regulation of TGF-β mRNA in mononuclear cells. Ann. N.Y. Acad. Sci. 778: 273-287.
18. OKUMURA, S., K. MCINTOSH & D. DRACHMAN. 1994. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann. Neurol. 36: 704-713.
19. DRACHMAN, D., S. OKUMURA, R. ADAMS & K. MCINTOSH. 1996. Oral tolerance in myasthenia gravis. Ann. N.Y. Acad. Sci. 778: 258-272.
20. UNWIN, N. 1993. Nicotinic acetylcholine receptor at 9 Å resolution. J. Mol. Biol. 229: 1101-1124.
21. BEROUKHIM, R. & N. UNWIN. 1995. Three-dimensional location of the main immunogenic region of the acetylcholine receptor. Neuron 15: 323-331.
22. DANI, J. & S. HEINEMANN. 1996. Molecular and cellular aspects of nicotine abuse. Neuron 16: 905-908.
23. DEL TORO, E., J. JUIZ, X. PENG, J. LINDSTROM & M. CRIADO. 1994. Immunocytochemical localization of the α 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J. Comp. Neurol. 349: 325-342.
24. ELGOYHEN, A., D. JOHNSON, J. BOULTER, D. VETTER & S. HEINEMANN. 1994. α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79: 705-715.
25. CONROY, W. & D. BERG. 1995. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem. 270: 4424-4431.
26. HORCH, H. & P. SARGENT. 1995. Perisynaptic surface distribution of multiple classes of nicotinic acetylcholine receptors on neurons in the chicken ciliary ganglion. J. Neurosci. 15: 7778-7795.
27. ZHANG, Z., J. COGGAN & D. BERG. 1996. Synaptic currents generated by neuronal acetylcholine receptors sensitive to α-bungarotoxin. Neuron 17: 1231-1240.
28. GRAY, R., A. RAJAN, K. RADCLIFFE, M. YAKEHIRO & J. DANI. 1996. Hippocampal synaptic transmission enhanced by low concentration of nicotine. Nature 383: 713-716.
29. WONNACOTT, S. 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20: 92-98.
30. ROMANO, S., P. PUGH, K. MCINTOSH & D. BERG. 1997. Neuronal-type acetylcholine receptors and regulation of α7 gene expression in vertebrate skeletal muscle. J. Neurobiol. 32: 69-80.
31. ROMANO, S., R. CORRIVEAU, R. SCHWARZ & D. BERG. 1997. Expression of the nicotinic receptor α7 gene in tendon and periosteum during early development. J. Neurochem. 68: 640-648.
32. SEQUELA, P., J. WADICHE, K. DINELLY-MILLER, J. DANI & J. PATRICK. 1993. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13: 596-604.
33. FUCHS, P. & B. MURROW. 1992. A novel cholinergic receptor mediates inhibition of chick cochlea hair cells. Proc. R. Soc. Lond. B 248: 35-40.
34. LIPTON, S. & S. KATER. 1989. Neurotransmitter regulation of neuronal outgrowth, plasticity, and survival. TINS 12: 265-270.
35. PUGH, P. & D. BERG. 1994. Neuronal acetylcholine receptors that bind α-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J. Neurosci. 14: 889-896.
36. PAPKE, R. 1993. The kinetic properties of neuronal nicotinic receptor: genetic basis of functional diversity. Prog. Neurobiol. 41: 509-531.
37. GERZANICH, V, A. KURYATOV, R. ANAND & J. LINDSTROM. 1997. "Orphan" α6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol. Pharmacol. 51: 320-327.
38. FORSAYETH, J. & E. KOBRIN. 1997. Formation of oligomers containing the β3 and β4 subunits of the rat nicotinic receptor. J. Neurosci. 17: 1531-1538.
39. WHITING, P. & J. LINDSTROM. 1988. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci. 8: 3395-3404.
40. ANAND, R., W. CONROY, R. SCHOEPFER, P. WHITING & J. LINDSTROM. 1991. Chicken neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266: 11192-11198.
41. MIHOVILOVIC, M. & A. ROSES. 1993. Expression of α3, α5, and β4 neuronal acetylcholine receptor subunit transcripts in normal and myasthenia gravis thymus. J. Immunol. 151: 6517-6524.
42. GRANDO, S., R. HORTON, E. PEREIRA, B. DIETHELMOKITA, P. GEORGE, E. ALBUQUERQUE & B. CONTI-FINE. 1995. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J. Invest. Dermatol. 105: 774-781.
43. VERNALLIS, A., W. CONROY & D. BERG. 1993. Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron 10: 451-464.
44. SWANSON, L., D. SIMMONS, P. WHITING & J. LINDSTROM. 1987. Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J. Neurosci. 7: 3334-3342.
45. LENOVERE, N., M. ZOLI & J. CHANGEUX. 1996. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8: 2428-2439.
46. WHITEHOUSE, P., A. MARTINO, K. MARCUS, R. ZWEIG, H. SINGER, D. PRICE & K. KELLAR. 1988. Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch. Neurol. 45: 722-724.
47. STEINLEIN, O., J. MULLEY, P. PROPPING, R. WALLACE, H. PHILLIPS, G. SUTHERLAND, I. SCHEFFER & S. BERKOVIC. 1995. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11: 201-203.
48. OHNO, K., H. WANG, M. MILONE, N. BREN, J. BRENGMAN, S. NAKANO, P. OUIRAM, J. PRUITT, S. SINE & A. ENGEL. 1996. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor e subunit. Neuron 17: 157-170.
49. PETO, R., A. LOPEZ, J. BOREHAM, M. THUN & C. HEATH. 1992. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 339: 1268-1278.
50. LUKAS, R. 1989. Pharmacological distinctions between functional nicotinic acetylcholine receptors in the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J. Pharmacol. Exp. Ther. 253: 51-57.
51. BENOWITZ, N., H. PROCHET & P. JACOB. 1990. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In Nicotine Psychopharmacology, p. 112-157. Oxford Sci. Pub. London/New York.
52. PENG, X., R. ANAND, P. WHITING & J. LINDSTROM. 1994. Nicotine-induced upregulation of neuronal nicotinic receptors results from a decrease in the rate of turnover. Mol. Pharmacol. 46: 523-530.
53. PENG, X., V GERZANICH, R. ANAND, F. WANG & J. LINDSTROM. 1997. Chronic nicotine treatment upregulates α3 AChRs and α7 AChRs expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51: 776-784.
54. FROEHNER, S. 1981. Identification of exposed and buried determinants of the membranebound acetylcholine receptor from Torpedo californica. Biochemistry 20: 4905-4915.
55. DAS, M. & J. LINDSTROM. 1991. Epitope mapping of antibodies to acetylcholine receptors. Biochemistry 30: 2470-2477.
56. LINDSTROM, J., B. EINARSON & J. MERLIE. 1978. Immunization of rats with polypeptide chains from Torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc. Natl. Acad. Sci. U.S.A. 75: 769-773.
57. KROLICK, K., T. YEH & S. EDLUND. 1996. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Cell. Immunol. 172: 10-20.
58. ORLEWSKI, P., M. MARRAUD, M. CUNG, V TSIKARIS, M. SAKARELLOS DAITSIOTIS, C. SAKARELLOS, E. VATZAKI & S. TZARTOS. 1996. Compared structures of the free nicotinic receptor main immunogenic region (MIR) decapeptide and the antibody bound [A(76)] MIR analogue: a molecular simulation from two-dimensional NMR data. Biopolymers 40: 419-432.
59. SAEDI, M., R. ANAND, W. CONROY & J. LINDSTROM. 1990. Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett. 267: 55-59.
60. WHITING, P., J. COOPER & J. LINDSTROM. 1987. Antibodies in sera from patients with myasthenia gravis do not bind to acetylcholine receptors from human brain. J. Neuroimmunol. 16: 205-213.
61. WEINER, H. 1997. Oral tolerance for the treatment of autoimmune diseases. Annu. Rev. Med. 48: 341-351.
62. HOHOL, M., S. KHOURY, S. COOK, E. ORAV, D. HAFLER & H. WEINER. 1996. Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. Ann. N.Y. Acad. Sci. 778: 243-250.
63. TRENTHAM, D. 1996. Evidence that type II collagen feeding can induce a durable therapeutic response in some patients with rheumatoid arthritis. Ann. N.Y. Acad. Sci. 778: 306-314.
64. WHITACRE, C., J. GIENAPP, A. MEYER, K. COX & N. JAVED. 1996. Treatment of autoimmune disease by oral tolerance to autoantigens. Clin. Immunol. Immunother. 80: 531-539.
65. GREGERSON, D., W. OBRITSCH & L. DONOSO. 1993. Oral tolerance in experimental autoimmune uveoretinitis. J. Immunol. 151: 5751-5761.
66. SUB, J., C. RASK, T. OLSSON, J. HOLMGREN & C. CZERKINSKY. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. U.S.A. 93: 7196-7201.
67. DICK, A., Y. CHENG, A. MCKINNON, J. LIVERSIDGE & J. FORRESTER. 1993. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. Br. J. Ophthalmol. 77: 171-175.
68. HARRISON, L., M. DEMPSEY COLLIER, D. KRAMER & K. TAKAHASHI. 1996. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184: 2167-2174.
69. METZLER, B. & D. WRAITH. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation, but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5: 1159-1165.
70. MELMS, A., G. MALCHERIK, U. GERN, H. WIETHOLTER, R. SCHOEPFER & J. LINDSTROM. 1992. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the α subunit: Ann. Neurol. 31: 311-318.
71. PROTTI, M., A. MANFREDI, R. HORTON, M. BELLONE & B. CONTI-TRONCONI. 1993. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol. Today 14: 363-368.
72. OLALE, F., V GERZANICH, A. KURYATOV, F. WANG & J. LINDSTROM. 1997. Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. In press.